Silibinin inhibits acetylcholinesterase activity and amyloid β peptide aggregation: a dual-target drug for the treatment of Alzheimer’s disease
2015 ◽
Vol 36
(5)
◽
pp. 1792-1807
◽
2018 ◽
Vol 66
(3)
◽
pp. 1145-1163
◽
Keyword(s):
Keyword(s):
Keyword(s):
2014 ◽
Vol 40
(3)
◽
pp. 643-657
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 8
(26)
◽
pp. 5776-5782
◽